Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neurokinin 1 receptor (NK1R) is a G protein-coupled receptor (GPCR) that primarily binds the neuropeptide substance P, but also interacts with other tachykinins such as neurokinins A and B. It is widely expressed in both the central and peripheral nervous systems, as well as in various non-neuronal tissues including immune cells, muscle, endothelial cells, and exocrine glands. NK1R plays roles in pain transmission, inflammation, and other physiological processes. Antagonists like aprepitant and netupitant are used for chemotherapy-induced nausea and vomiting.
NK1R antagonists induce long-lasting conformational changes that block substance P from activating the receptor.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurokinin 1 Receptor (NK1R).